(Approval lapsed) Pantoprazole Sodium for Injection, 40mg per vial

For short-term use where oral therapy is not appropriate for the following conditions:

• Symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion, e.g. duodenal ulcer, gastric ulcer, reflux oesophagitis, gastrointestinal lesions refractory to H2 blockers, Zollinger-Ellison Syndrome.
• Maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis.

Note: Patients whose gastric or duodenal ulceration is not associated with ingestion of nonsteroidal anti-inflammatory drugs require treatment with antimicrobial agents in addition to antisecretory medicines, whether on first presentation or recurrence